HomeGUD • TSE
add
Knight Therapeutics Inc
Previous close
$5.83
Day range
$5.76 - $5.91
Year range
$5.09 - $6.45
Market cap
586.96M CAD
Avg Volume
78.08K
P/E ratio
138.14
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 96.86M | 30.55% |
Operating expense | 43.31M | 26.28% |
Net income | 10.74M | 144.13% |
Net profit margin | 11.08 | 133.79% |
Earnings per share | 0.11 | 175.39% |
EBITDA | 6.46M | -17.88% |
Effective tax rate | -36.32% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 172.84M | 1.75% |
Total assets | 963.80M | 1.94% |
Total liabilities | 168.69M | -15.07% |
Total equity | 795.10M | — |
Shares outstanding | 100.05M | — |
Price to book | 0.73 | — |
Return on assets | -0.77% | — |
Return on capital | -0.88% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 10.74M | 144.13% |
Cash from operations | 1.47M | -91.81% |
Cash from investing | 18.05M | 1,049.45% |
Cash from financing | -15.35M | 56.99% |
Net change in cash | 6.35M | 134.04% |
Free cash flow | 4.96M | -91.80% |
About
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Founded
2014
Headquarters
Website
Employees
745
